Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Harrison

Showing results (31-40 of 261) with videos related to

Pageof 27
Sort By:
Journal of Medical Economics|July 2, 2013
Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitisMachaon Bonafede, George J Joseph, Nicole Princic, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 30, 2005
Hematopoietic stem cell trafficking in liver injuryEvangelos Dalakas, Philip N Newsome, David J Harrison, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 23, 2013
Use of microarray analysis to investigate EMT gene signaturesAndrew H Sims, Alexey A Larionov, David J Harrison, et al.
Epigenomics|November 29, 2013
5-hydroxymethylcytosine profiling as an indicator of cellular stateAlexander Laird, John P Thomson, David J Harrison, et al.
BMC Cell Biology|November 22, 2002
Absence of p53 in Clara cells favours multinucleation and loss of cell cycle arrestChristopher J Armit, Shirley O'Dea, Alan R Clarke, et al.
Stem Cells (Dayton, Ohio)|November 13, 2004
Potential of hematopoietic stem cell therapy in hepatology: a critical reviewSteven Masson, David J Harrison, John N Plevris, et al.
Nature Reviews. Clinical Oncology|July 8, 2009
Systems pathology--taking molecular pathology into a new dimensionDana Faratian, Robert G Clyde, John W Crawford, et al.
European Urology|March 29, 2014
The molecular biology of renal cancer: another piece of the puzzleGrant D Stewart, David J Harrison, Daniel M Berney, et al.
The American Journal of Managed Care|May 13, 2008
The cost of treating skeletal-related events in patients with prostate cancerMaureen J Lage, Beth L Barber, David J Harrison, et al.
Clinical Therapeutics|July 27, 2014
Cost of biologics per treated patient across immune-mediated inflammatory disease indications in a pharmacy benefit management setting: a retrospective cohort studyNing Wu, Yuan-Chi Daisy Lee, Neel Shah, et al.
Pageof 27

Showing results (31-40 of 261) with videos related to

Sort By:
Pageof 27
Journal of Medical Economics|July 2, 2013
Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitisMachaon Bonafede, George J Joseph, Nicole Princic, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 30, 2005
Hematopoietic stem cell trafficking in liver injuryEvangelos Dalakas, Philip N Newsome, David J Harrison, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 23, 2013
Use of microarray analysis to investigate EMT gene signaturesAndrew H Sims, Alexey A Larionov, David J Harrison, et al.
Epigenomics|November 29, 2013
5-hydroxymethylcytosine profiling as an indicator of cellular stateAlexander Laird, John P Thomson, David J Harrison, et al.
BMC Cell Biology|November 22, 2002
Absence of p53 in Clara cells favours multinucleation and loss of cell cycle arrestChristopher J Armit, Shirley O'Dea, Alan R Clarke, et al.
Stem Cells (Dayton, Ohio)|November 13, 2004
Potential of hematopoietic stem cell therapy in hepatology: a critical reviewSteven Masson, David J Harrison, John N Plevris, et al.
Nature Reviews. Clinical Oncology|July 8, 2009
Systems pathology--taking molecular pathology into a new dimensionDana Faratian, Robert G Clyde, John W Crawford, et al.
European Urology|March 29, 2014
The molecular biology of renal cancer: another piece of the puzzleGrant D Stewart, David J Harrison, Daniel M Berney, et al.
The American Journal of Managed Care|May 13, 2008
The cost of treating skeletal-related events in patients with prostate cancerMaureen J Lage, Beth L Barber, David J Harrison, et al.
Clinical Therapeutics|July 27, 2014
Cost of biologics per treated patient across immune-mediated inflammatory disease indications in a pharmacy benefit management setting: a retrospective cohort studyNing Wu, Yuan-Chi Daisy Lee, Neel Shah, et al.
Pageof 27